These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35314675)

  • 1. Extramedullary disease in multiple myeloma: a systematic literature review.
    Bladé J; Beksac M; Caers J; Jurczyszyn A; von Lilienfeld-Toal M; Moreau P; Rasche L; Rosiñol L; Usmani SZ; Zamagni E; Richardson P
    Blood Cancer J; 2022 Mar; 12(3):45. PubMed ID: 35314675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
    Rosiñol L; Beksac M; Zamagni E; Van de Donk NWCJ; Anderson KC; Badros A; Caers J; Cavo M; Dimopoulos MA; Dispenzieri A; Einsele H; Engelhardt M; Fernández de Larrea C; Gahrton G; Gay F; Hájek R; Hungria V; Jurczyszyn A; Kröger N; Kyle RA; Leal da Costa F; Leleu X; Lentzsch S; Mateos MV; Merlini G; Mohty M; Moreau P; Rasche L; Reece D; Sezer O; Sonneveld P; Usmani SZ; Vanderkerken K; Vesole DH; Waage A; Zweegman S; Richardson PG; Bladé J
    Br J Haematol; 2021 Aug; 194(3):496-507. PubMed ID: 33724461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extramedullary multiple myeloma.
    Weinstock M; Ghobrial IM
    Leuk Lymphoma; 2013 Jun; 54(6):1135-41. PubMed ID: 23210572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.
    Weinstock M; Aljawai Y; Morgan EA; Laubach J; Gannon M; Roccaro AM; Varga C; Mitsiades CS; Paba-Prada C; Schlossman R; Munshi N; Anderson KC; Richardson PP; Weller E; Ghobrial IM
    Br J Haematol; 2015 Jun; 169(6):851-8. PubMed ID: 25833301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Abnormalities in Extramedullary Multiple Myeloma.
    McAvera R; Quinn J; Murphy P; Glavey S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.
    Varga C; Xie W; Laubach J; Ghobrial IM; O'Donnell EK; Weinstock M; Paba-Prada C; Warren D; Maglio ME; Schlossman R; Munshi NC; Raje N; Weller E; Anderson KC; Mitsiades CS; Richardson PG
    Br J Haematol; 2015 Jun; 169(6):843-50. PubMed ID: 26032514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and survival outcomes of newly diagnosed multiple myeloma patients presenting with extramedullary disease: A retrospective study.
    Gao S; Li Q; Dong F; Yang P; Chen Y; Wang J; Wang Y; Jing H
    Leuk Res; 2022 Apr; 115():106793. PubMed ID: 35248783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
    Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
    Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.
    Bladé J; Fernández de Larrea C; Rosiñol L; Cibeira MT; Jiménez R; Powles R
    J Clin Oncol; 2011 Oct; 29(28):3805-12. PubMed ID: 21900099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extramedullary Plasmacytomas of the Oral Cavity: A Case Report and Review of the Literature.
    Bavarian R; Treister NS
    J Cancer Allied Spec; 2021; 7(2):e417. PubMed ID: 37197217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse skeletal muscle extramedullary plasmacytomas: a rare case and review of the literature.
    Moore RD; Nelson SM; Cecava ND
    Skeletal Radiol; 2020 Dec; 49(12):2087-2093. PubMed ID: 32556470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
    Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
    J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients.
    Avivi I; Cohen YC; Suska A; Shragai T; Mikala G; Garderet L; Seny GM; Glickman S; Jayabalan DS; Niesvizky R; Gozzetti A; Wiśniewska-Piąty K; Waszczuk-Gajda A; Usnarska-Zubkiewicz L; Hus I; Guzicka R; Radocha J; Milunovic V; Davila J; Gentile M; Castillo JJ; Jurczyszyn A
    Am J Hematol; 2019 Oct; 94(10):1132-1140. PubMed ID: 31334859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome.
    Beksac M; Seval GC; Kanellias N; Coriu D; Rosiñol L; Ozet G; Goranova-Marinova V; Unal A; Bila J; Ozsan H; Ivanaj A; Balić LI; Kastritis E; Bladé J; Dimopoulos MA
    Haematologica; 2020 Jan; 105(1):201-208. PubMed ID: 31278209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extramedullary Disease in Multiple Myeloma.
    Jagosky MH; Usmani SZ
    Curr Hematol Malig Rep; 2020 Apr; 15(2):62-71. PubMed ID: 32198576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myeloma.
    Song Y; Du J; Jin X; Li H; Jia C; Liu Y; Li K; Zhou D; Zhuang J
    Eur J Haematol; 2024 Dec; 113(6):824-832. PubMed ID: 39191670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
    Jiménez-Segura R; Granell M; Gironella M; Abella E; García-Guiñón A; Oriol A; Cabezudo E; Clapés V; Soler JA; Escoda L; López-Pardo J; Fernández de Larrea C; Cibeira MT; Tovar N; Isola I; Bladé J; Rosiñol L;
    Eur J Haematol; 2019 May; 102(5):389-394. PubMed ID: 30719772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramedullary disease in multiple myeloma.
    Bansal R; Rakshit S; Kumar S
    Blood Cancer J; 2021 Sep; 11(9):161. PubMed ID: 34588423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease.
    Tucker SM; Zaihra T
    Orbit; 2023 Dec; 42(6):603-611. PubMed ID: 36697375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases.
    Deng S; Xu Y; An G; Sui W; Zou D; Zhao Y; Qi J; Li F; Hao M; Qiu L
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):286-91. PubMed ID: 25640025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.